Indianapolis, IN - A European postmarketing surveillance study of Guidant Corporation's cardiac resynchronization device for use in heart failure (HF) has shown that 60% of the 1000 patients using it ...

Please provide your email address to receive an email when new articles are posted on . Pacemakers or implanted cardiac defibrillators that were retrieved postmortem, resterilized and reused in ...

Dr. Hunter Champion answers the question: 'What Is A Biventricular Pacemaker?' — -- Question: What is a biventricular pacemaker or cardiac resynchronization therapy (also called a CRT device), ...

Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. An implantable device that shocks an erratically beating heart back into ...

MINNEAPOLIS - Medtronic, Inc. today announced CE (Conformité Européenne) Mark receipt and the European launch of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P. The Viva CRT-P is ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Remote monitoring of patients with implantable cardiac devices reduced the mortality rate for cardiac patients by 50 percent and improved their clinical status by nearly 10 percent in a randomized ...

Results from the Cardiac Resynchronization—Heart Failure (CARE-HF) study support the use of implantable cardiac-resynchronization devices in patients with heart failure due to left-ventricular ...

LAKE OSWEGO, Ore. & BERLIN--(BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, announced today the US market ...